"Designing Growth Strategies is in our DNA"

U.S. Livestock Vaccines Market Size, Share & COVID-19 Impact Analysis, By Type (Inactivated, Live Attenuated, Recombinant, and Others), By Animal Type (Bovine, Swine/ Porcine, Poultry, and Others), By Route of Administration (Oral, Parenteral, and Others), By Distributional Channel (Veterinary Hospitals, Veterinary Clinics, and Others), and Country Forecast, 2023-2030

Last Updated: July 08, 2024 | Format: PDF | Report ID: FBI108431

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The U.S. livestock vaccines market size was worth USD 2.36 billion in 2022 and is projected to grow at a CAGR of 6.0% during the forecast period.


The U.S. has seen a high prevalence of livestock and zoonotic diseases, which has increased the number of farm animals being vaccinated. This has led to the government's growing focus on preventing and controlling these diseases and the increase in the introduction of vaccines by the market players, which is expected to boost the demand for vaccines in the coming years.


For instance, according to the article published by National Foundation for Infectious Diseases in March 2023, in the U.S., approximately 5,000 animal rabies cases are reported each year.


The growing adoption of vaccines among farm animal owners and veterinarians driven, coupled with the awareness campaigns initiated to understand vaccination programmes for the treatment of livestock suffering from diseases, is expected to propel the market.


In 2020, during the COVID-19 pandemic, the market experienced slow growth in the U.S. The slow growth is attributed to fewer animal visits to hospitals and clinics for vaccination management compared to the pre-pandemic period.


LATEST TRENDS


Technological Upgradation Across Various Vaccines Types Identified as Key Market Trend


 


In recent years, the market players are continuously focusing on the technological advancement of various types of vaccines, such as live attenuated vaccine, recombinant vaccines, and vector vaccines to prevent the diseases spread among the farm animals effectively.


Furthermore, the advancements in live attenuation, i.e., modified live livestock vaccines, which offer advantages over other livestock vaccines, are anticipated to boost the adoption in the country.  For instance, In January 2021, Zoetis Services LLC launched Poulvac, Procerta HVT-IBD, a modified live vaccine for poultry to protect them from infectious bursal disease (IBD) viruses.


The advantages include the ability to provide rapid and long-lasting immunity and the potential for stronger and broader immune responses due to the presence of live, attenuated pathogens.


DRIVING FACTOR


Government Efforts to Promote Animal Health and Manage Livestock Related Diseases to Augment Growth Prospects


The government has increased its focus on implementing vaccination programs in the U.S. to protect the livestock population from contagious diseases. These vaccination programs are promoted by government as a preventive measure that is expected to encourage livestock owners and farmers to vaccinate their animals.



  • In July 2020, the U.S. Department of Agriculture (USDA) invested USD 27.1 million to purchase Foot-And-Mouth Disease (FMD) vaccines for the National Animal Vaccine and Veterinary Countermeasures Bank. The purchase gave the government the means to respond to animal disease outbreaks.


The confluence of these factors is anticipated to boost the U.S. livestock vaccines market growth in the coming years.


Request a Free sample to learn more about this report.


In the U.S., 42 commercial flocks were impacted by the highly pathogenic avian influenza, and 220 equines were impacted by the West Nile virus in 2022.


RESTRAINING FACTORS


Growing Concerns Over Vaccine Failure Could Hinder the Market Growth 


Despite the increased adoption of vaccines for farm animals in the country, the risk associated with the adverse effects of these products is a point of concern. These livestock vaccines may occasionally lead to allergic reactions, injection site reactions, or other animal side effects. These adverse effects are anticipated to create hesitancy among livestock animal owners to continue vaccinating their livestock, significantly impacting vaccine adoption rates in the country.


SEGMENTATION


By Type Analysis


Based on type, this market is segmented into inactivated, live attenuated, recombinant, and others.


The live attenuated segment held a larger U.S. livestock vaccines market share in 2022 due to the increasing number of launches of advanced live attenuated vaccines for farm animals coupled with the growing outbreaks of diseases in the country.



  • For instance, in February 2020, Merck Animal Health (Merck & Co., Inc.) launched Nasalgen 3, a modified live virus for cattle, to prevent them from pneumonia-causing viral pathogens.


Furthermore, the development of live attenuated vaccines for swine which are given intramuscularly is expected to boost the segmental growth.


By Animal Type Analysis


Based on the animal type, the market is segmented into bovine, swine/ porcine, poultry, and others.


The poultry segment is projected to grow at the highest CAGR during the forecast period, 2023-2030. The highest CAGR is due to the increasing initiatives by companies to expand their poultry vaccine portfolio through product launches in the market.



  • For instance, in October 2020, Boehringer Ingelheim International GmbH’s U.S. Animal Health Business launched VAXXITEK HVT+IBD+ILT, a recombinant vaccine to protect poultry from three diseases.


Furthermore, the presence of livestock and zoonotic diseases in poultry is expected to boost the adoption of vaccines, thereby propelling segmental growth.


By Route of Administration Analysis


Based on route of administration, the U.S. livestock vaccines market is segmented into oral, parenteral, and others.


In 2022, the parenteral segment held a larger share of the market. The segmental growth is attributed to the continuous research and development in the parenteral vaccines by leading players is further anticipated to lead to a significant growth of this segment during the forecast period.



  • For instance, in January 2021, Zoetis Services LLC launched Poulvac Procerta HVT-IBD, a subcutaneous injection, which provides early protection against the contemporary infectious bursal disease (IBD) viruses confronting U.S. broilers.


By Distribution Channel Analysis


Based on distribution channel, the U.S. livestock vaccines market is segmented into veterinary hospitals, veterinary clinics, and others.


The veterinary clinics held a larger share in 2022 and is expected to grow at the highest CAGR during the forecast period. The growth is due to increasing demand for vaccines for farm animals, increased animal disease prevalence, and increased investment by governments and other organizations to improve veterinary clinics.


KEY INDUSTRY PLAYERS


In terms of the competitive landscape, the market depicts the presence of prominent and emerging companies operating in the market. Leading market players, such as Boehringer Ingelheim International GmbH, Merck Animal Health (Merck & Co., Inc.), and Zoetis Services LLC, have a significant market share. Boehringer Ingelheim International GmbH is a prominent company due to its strong direct presence and broad vaccine portfolio for farm animals.


Some other companies with a considerable presence in the U.S. market include Virbac, Phibro Animal Health Corporation, Vaxxinova International BV and Others, and other small & medium-sized players. These companies are focusing on strategic moves, such as launching livestock vaccines to strengthen their portfolio is expected to propel their share in the market.


LIST OF KEY COMPANIES PROFILED:



KEY INDUSTRY DEVELOPMENTS: 



  • July 2023- The College of Veterinary Medicine of the Kansas State University announced the inauguration of a Center on Vaccine Evaluation and Alternatives for Antimicrobials (CVEAA). The center will support research and development of new and innovative livestock and animal vaccines.

  • January 2021- Zoetis Services LLC launched Poulvac, Procerta HVT-IBD vaccine, to protect poultry from infectious bursal disease (IBD) viruses and broadened its product portfolio.

  • August 2020 - Merck Animal Health (Merck & Co., Inc.) gained rights to VECOXAN, including in the U.S., for calves and lambs to prevent them from coccidiosis.


REPORT COVERAGE


An Infographic Representation of U.S. Livestock Vaccines Market

To get information on various segments, share your queries with us



The market report provides a detailed analysis of the market. It focuses on key aspects, such as vaccination programs, veterinary vaccination rates, and market dynamics. Additionally, it includes an overview of market segments, key industry developments such as mergers and acquisitions, and technological advancements in the market. Besides this, the report also offers insights into the epidemiology of key animal diseases in the country. Additionally, it encompasses the impact of COVID-19, and the industry overview during the pandemic is covered in the report.


Report Scope & Segmentation



















































ATTRIBUTE



DETAILS



Study Period



2019-2030



Base Year



2022



Estimated Year 



2023



Forecast Period



2023-2030



Historical Period



2019-2021



Growth Rate



CAGR of 6.0% from 2023 to 2030



Unit



Value (USD Billion)



Segmentation



By Type



  • Inactivated

  • Live Attenuated

  • Recombinant

  • Others



By Animal Type



  • Bovine

  • Swine/Porcine

  • Poultry

  • Others



By Route of Administration



  • Oral

  • Parenteral

  • Others



By Distribution Channel



  • Veterinary Hospitals

  • Veterinary Clinics

  • Others






Frequently Asked Questions

Fortune Business Insights says that the U.S. market was worth USD 2.36 billion in 2022.

The market is expected to exhibit a CAGR of 6.0% during the forecast period (2023-2030).

The veterinary clinics are set to lead the market by distribution channel.

Boehringer Ingelheim International GmbH, Merck Animal Health (Merck & Co., Inc.), and Zoetis Services LLC are the top players in the market.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • 2019-2030
  • 2022
  • 2019-2021
  • 80

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X